U.S., Nov. 26 -- An application to own the trademark for 'SUPRAME' has been filed on Mar. 26, 2025.
Owner(s):
Immatics Biotechnologies GmbH; Paul-Ehrlich-Strasse 15, , GERMANY
Goods and/or Services:
For: Conducting of medical, scientific and clinical research in the field of engineered T-cell receptor-based immunotherapy against solid cancer; medical and scientific research in the nature of conducting clinical trials for others in the field of engineered T-cell receptor-based immunotherapy against solid cancer, and providing corresponding medical and scientific research information
Class(es): 100, 101
Mark Drawing Type: 4 - STANDARD CHARACTER MARK
https://eog-tmng.uspto.gov/#/issueDate=2025-11-25&serialNumber=99104160
Disclaimer: Cu...